Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Antiseptics and Disinfectants: Activity, Action, and Resistance
1999 Standout
Comparative Study of the Susceptibilities of Major Epidemic Clones of Methicillin-Resistant Staphylococcus aureus to Oxacillin and to the New Broad-Spectrum Cephalosporin Ceftobiprole
2008
Infective Endocarditis
2005 Standout
Cochrane Database of Systematic Reviews
2003 Standout
SM-216601, a Novel Parenteral 1β-Methylcarbapenem: Structure-activity Relationships of Antibacterial Activity and Neurotoxicity in Mice
2005
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
An International Prospective Study of Pneumococcal Bacteremia: Correlation with In Vitro Resistance, Antibiotics Administered, and Clinical Outcome
2003
Plasmid-borne AmpC β-lactamases
2002
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
β-lactams against methicillin-resistant
2005
Antimicrobial-resistantStreptococcus pneumoniae: trends and management
2008
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Taking inventory: antibacterial agents currently at or beyond Phase 1
2004
Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical Center
2003
Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
2011
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
A Randomized, Double-Blind Trial Comparing Ceftobiprole Medocaril with Vancomycin plus Ceftazidime for the Treatment of Patients with Complicated Skin and Skin-Structure Infections
2008
Natural products: An evolving role in future drug discovery
2011 Standout
Sensitivity of biofilms to antimicrobial agents
1993
Discrepancies between Various Methods in Susceptibility Testing and Epidemiological Analysis of Stenotrophomonas maltophilia Clinical Isolates
2010
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Anti-MRSA β-lactams in development
2006
An Outbreak of Lymphadenitis Associated with Stenotrophomonas (Xanthomonas) maltophilia in Omani Goats
2003
The Bacterial Cell Envelope
2010 Standout
The Diagnosis and Management of Acute Otitis Media
2013 Standout
Cephalosporins in clinical development
2004
Structural basis for the β lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus
2002
In vitro activity profile of ceftobiprole, an anti-MRSA cephalosporin, against recent Gram-positive and Gram-negative isolates of European origin
2008
Epidemiologic Changes in Bacteremic Pneumococcal Disease in Patients With Human Immunodeficiency Virus in the Era of Highly Active Antiretroviral Therapy
2005
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
Synergism between natural products and antibiotics against infectious diseases
2008 Standout
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
2008 Standout
Antibacterial resistance worldwide: causes, challenges and responses
2004 Standout
The Basis for Resistance to β-Lactam Antibiotics by Penicillin-binding Protein 2a of Methicillin-resistant Staphylococcus aureus
2004
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
The Evolving Role of Chemical Synthesis in Antibacterial Drug Discovery
2014
Treatment of Bacterial Meningitis
1997
Ceftobiprole: a novel cephalosporin with activity against Gram-positive and Gram-negative pathogens, including methicillin-resistant Staphylococcus aureus (MRSA)
2009
Claims of equivalence in randomized controlled trials of the treatment of bacterial meningitis in children
2002
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Novel β-lactam antibiotics and inhibitor combinations
2008
In-vitro profile of a new β-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus
2007
MENINGITIS
1993
β-Lactams and β-Lactamase Inhibitors: An Overview
2016 Standout
How many modes of action should an antibiotic have?
2008
In vitro susceptibility of Stenotrophomonas maltophilia isolates: comparison of disc diffusion, Etest and agar dilution methods
2004
Activity of ceftobiprole against methicillin-resistant Staphylococcus aureus strains with reduced susceptibility to daptomycin, linezolid or vancomycin, and strains with defined SCCmec types
2013
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Meningitis Due to Xanthomonas maltophilia: Case Report and Review
1994
Sputum Isolation of Wangiella dermatitidis in Patients with Cystic Fibrosis
2001
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
Reporting of Noninferiority and Equivalence Randomized Trials
2012 Standout
Natural products to drugs: natural product derived compounds in clinical trials
2005
Infective endocarditis
2004 Standout
Solving staphylococcal resistance to β-lactams
2003
Antimicrobial Chemotherapy for Legionnaires' Disease: A Review
1995
Penicillin-binding proteins and β-lactam resistance
2008
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Acinetobacter baumannii : Emergence of a Successful Pathogen
2008 Standout
In Vitro and In Vivo Antibacterial Activities of SM-216601, a New Broad-Spectrum Parenteral Carbapenem
2005
Emergence of Streptococcus pneumoniae with Very-High-Level Resistance to Penicillin
2004
New Method for Laboratory Detection of AmpC β-Lactamases in Escherichia coli and Klebsiella pneumoniae
2004
Analysis of the Structural Diversity, Substitution Patterns, and Frequency of Nitrogen Heterocycles among U.S. FDA Approved Pharmaceuticals
2014 Standout
Zygomycetes in Human Disease
2000 Standout
Saprophytic Molds as Agents of Cutaneous and Subcutaneous Infection in the Immunocompromised Host
1986
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
AmpC β-Lactamases
2009 Standout
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
2013 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Acute otitis media in pediatric medicine: current issues in epidemiology, diagnosis, and management.
2003
In Vitro Activities of ME1036 (CP5609), a Novel Parenteral Carbapenem, against Methicillin-Resistant Staphylococci
2004
Bacterial Biofilms: A Common Cause of Persistent Infections
1999 StandoutScience
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
In Vitro and In Vivo Activities of Novel 2-(Thiazol-2-ylthio)-1β-Methylcarbapenems with Potent Activities against Multiresistant Gram-Positive Bacteria
2003
Using the shortwave infrared to image middle ear pathologies
2016 StandoutNobel
Legionella and Legionnaires' Disease: 25 Years of Investigation
2002 Standout
Anti-MRSA β-lactams in development, with a focus on ceftobiprole: the first anti-MRSA β-lactam to demonstrate clinical efficacy
2007
In vitro susceptibility of Stenotrophomonas maltophilia to various antimicrobial combinations
2001
Granular Layer in the Periplasmic Space of Gram-Positive Bacteria and Fine Structures ofEnterococcus gallinarumandStreptococcus gordoniiSepta Revealed by Cryo-Electron Microscopy of Vitreous Sections
2006 StandoutNobel
Three Decades of β-Lactamase Inhibitors
2010 Standout
Ceftobiprole: An Extended-Spectrum Anti–Methicillin-Resistant Staphylococcus aureus Cephalosporin
2008
Ceftobiprole: A New Option for Treatment of Skin and Soft-Tissue Infections due to Methicillin-Resistant Staphylococcus aureus
2008
Plasmid-Mediated Antimicrobial Resistance inSalmonella enterica
2003
Natural product and natural product derived drugs in clinical trials
2014 Standout
2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infectionsa
2012 Standout
Ceftobiprole: drug evaluation and place in therapy
2019
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
RWJ-54428 (MC-02,479), a New Cephalosporin with High Affinity for Penicillin-Binding Proteins, Including PBP 2a, and Stability to Staphylococcal Beta-Lactamases
2003
Interactions of Ceftobiprole with β-Lactamases from Molecular Classes A to D
2007
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
Practice Guidelines for the Management of Bacterial Meningitis
2004 Standout
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Origins and Evolution of Antibiotic Resistance
2010 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria
2007
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Single-Dose Pharmacokinetics and Safety of a Novel Broad-Spectrum Cephalosporin (BAL5788) in Healthy Volunteers
2004
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
New antimicrobial agents for the treatment of Gram-positive bacterial infections
2008
Works of P. Hohl being referenced
Escherichia coli producing a cephamycinase (CMY-2) from a patient from the Libyan–Tunisian border region
1998
In vitro susceptibility of 33 clinical case isolates of Xanthomonas maltophilia
1991
In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil
1989
FatalLegionella pneumophila pneumonia: Treatment failure despite early sequential oral-parenteral amoxicillin-clavulanic acid therapy
1992
Effect of method, medium, pH and inoculum on the in-vitro antibacterial activities of fleroxacin and norfloxacin
1988
The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections
2002
Short course single daily ceftriaxone monotherapy for acute bacterial meningitis in children: Results of a Swiss multicenter study. Part I: Clinical results
1990
LB11058, a New Cephalosporin with High Penicillin-Binding Protein 2a Affinity and Activity in Experimental Endocarditis Due to Homogeneously Methicillin-Resistant Staphylococcus aureus
2004
Infections Due to Wangiella dermatitidis in Humans: Report of the First Documented Case from the United States and a Review of the Literature
1983
In Vitro and In Vivo Properties of Ro 63-9141, a Novel Broad-Spectrum Cephalosporin with Activity against Methicillin-Resistant Staphylococci
2001
BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental Endocarditis
2002